Literature DB >> 18718557

The evolution of Staphylococcus aureus.

Ruud H Deurenberg1, Ellen E Stobberingh.   

Abstract

A broad variety of infections, ranging from minor infections of the skin to post-operative wound infections can be caused by Staphylococcus aureus. The adaptive power of S. aureus to antibiotics leaded, in the early 1960s, to the emergence of methicillin-resistant S. aureus (MRSA). The cause of resistance to methicillin and all other beta-lactam antibiotics is the mecA gene, which is situated on a mobile genetic element, the staphylococcal cassette chromosome mec (SCCmec). Seven major variants of SCCmec, type I to VII, are distinguished. The most important techniques used to investigate the molecular epidemiology of S. aureus are pulsed-field gel electrophoresis (PFGE), multilocus sequence typing (MLST), S. aureus protein A (spa) typing and SCCmec typing (only for MRSA). These techniques have been used to study the evolution of the MRSA clones that have emerged since the early 1960s, and to study their subsequent worldwide dissemination. The early MRSA clones were hospital-associated (HA-MRSA). However, from the late 1990s, community-associated MRSA (CA-MRSA) clones emerged worldwide. CA-MRSA harbors SCCmec type IV, V or VII, the majority belong to other S. aureus lineages compared to HA-MRSA, and CA-MRSA is often associated with the presence of the toxin Panton-Valentine leukocidin (PVL). However, during recent years, the distinction between HA-MRSA and CA-MRSA has started to disappear, and CA-MRSA is now endemic in many US hospitals. MRSA probably originated trough the transfer of SCCmec into a limited number of methicillin-sensitive S. aureus (MSSA) lineages. This review describes the latest observations about the structure of SCCmec, the techniques used to study the molecular epidemiology and evolution of S. aureus as well as some challenges that researchers face in the future.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18718557     DOI: 10.1016/j.meegid.2008.07.007

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  170 in total

1.  Restriction modification (RM) tests associated to additional molecular markers for screening prevalent MRSA clones in Brazil.

Authors:  C O Beltrame; A M N Botelho; M C Silva-Carvalho; R R Souza; R R Bonelli; M S Ramundo; M A Guimarães; L R Coelho; A M S Figueiredo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-01-13       Impact factor: 3.267

2.  Diversity of staphylococcal cassette chromosome mec elements in predominant methicillin-resistant Staphylococcus aureus clones in a small geographic area.

Authors:  Patrick Basset; Laurence Senn; Valérie Vogel; Giorgio Zanetti; Dominique S Blanc
Journal:  Antimicrob Agents Chemother       Date:  2010-08-16       Impact factor: 5.191

Review 3.  Mechanisms of resistance and clinical relevance of resistance to β-lactams, glycopeptides, and fluoroquinolones.

Authors:  Louis B Rice
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

4.  Nasal carriage of Staphylococcus aureus in healthy humans with different levels of contact with animals in Tunisia: genetic lineages, methicillin resistance, and virulence factors.

Authors:  K Ben Slama; H Gharsa; N Klibi; A Jouini; C Lozano; E Gómez-Sanz; M Zarazaga; A Boudabous; C Torres
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-11-11       Impact factor: 3.267

5.  Prevalence of Enterotoxin Genes and spa Genotypes of Methicillin-resistant Staphylococcus aureus from a Tertiary Care Hospital in China.

Authors:  Yanmeng Li; Ruike Zhao; Xianfeng Zhang; Qingzhen Han; Xuefeng Qian; Guohao Gu; Jinfang Shi; Jie Xu
Journal:  J Clin Diagn Res       Date:  2015-05-01

Review 6.  Molecular basis and phenotype of methicillin resistance in Staphylococcus aureus and insights into new beta-lactams that meet the challenge.

Authors:  Leticia I Llarrull; Jed F Fisher; Shahriar Mobashery
Journal:  Antimicrob Agents Chemother       Date:  2009-05-26       Impact factor: 5.191

7.  Methicillin-resistant Staphylococcus aureus in Zimbabwe.

Authors:  Kathrine Mauchaza; Farai D Madzimbamuto; Seymour Waner
Journal:  Ghana Med J       Date:  2016-06

Review 8.  Therapeutics and delivery vehicles for local treatment of osteomyelitis.

Authors:  Leah H Cobb; Emily M McCabe; Lauren B Priddy
Journal:  J Orthop Res       Date:  2020-04-21       Impact factor: 3.494

9.  Staphylococcus aureus nitric oxide synthase (saNOS) modulates aerobic respiratory metabolism and cell physiology.

Authors:  Austin B Mogen; Ronan K Carroll; Kimberly L James; Genevy Lima; Dona Silva; Jeffrey A Culver; Christopher Petucci; Lindsey N Shaw; Kelly C Rice
Journal:  Mol Microbiol       Date:  2017-05-10       Impact factor: 3.501

10.  Cooccurrence of predominant Panton-Valentine leukocidin-positive sequence type (ST) 152 and multidrug-resistant ST 241 Staphylococcus aureus clones in Nigerian hospitals.

Authors:  Kenneth O Okon; Patrick Basset; Auwalu Uba; Johnson Lin; Bukola Oyawoye; Adebayo O Shittu; Dominique S Blanc
Journal:  J Clin Microbiol       Date:  2009-07-15       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.